Compositions and methods for viral sensitization
US-2024360115-A1 · Oct 31, 2024 · US
Novel bacteriophage having ability to specifically kill clostridium perfringens and antibacterial composition comprising the same
US2024150725A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024150725-A1 |
| Application number | US-202118278775-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 15, 2021 |
| Priority date | Feb 25, 2021 |
| Publication date | May 9, 2024 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates to a novel bacteriophage having ability to specifically kill Clostridium perfringens and an antibacterial composition comprising the same. The novel bacteriophage CJ_CP_20-25 has the effect of specifically killing Clostridium perfringens, exhibits excellent acid resistance and heat resistance, and can thus be widely used in antibiotics, feed additives, drinking water additives, feed, drinking water, disinfectants, or cleaning agents for the prevention or treatment of infectious diseases caused by Clostridium perfringens.
First claim
Opening claim text (preview).
1 . A bacteriophage CJ_CP_20-25 that has ability to specifically kill Clostridium perfringens (CP) and is deposited with accession number KCCM12934P. 2 . A composition for prevention or treatment of infectious diseases caused by Clostridium perfringens comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 3 . The composition according to claim 2 , wherein the infectious diseases caused by Clostridium perfringens are necrotic enteritis. 4 . An antibiotic comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 5 . A feed additive comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 6 . Feed comprising the feed additive according to claim 5 . 7 . A drinking water additive comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 8 . Drinking water comprising the drinking water additive according to claim 7 . 9 . A disinfectant comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 10 . A cleaning agent comprising the bacteriophage CJ_CP_20-25 according to claim 1 as an active ingredient. 11 . A method for preventing or treating infectious diseases caused by Clostridium perfringens , the method comprising administering the bacteriophage CJ_CP_20-25 according to claim 1 or the composition according to claim 2 to an animal other than a human. 12 . The method according to claim 11 , wherein the infectious diseases caused by Clostridium perfringens are necrotic enteritis.
Assignees
Inventors
Classifications
- C12N7/00Primary
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
Uses of virus other than therapeutic or vaccine, e.g. disinfectant · CPC title
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent · CPC title
Methods of production or purification of viral material · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2024150725A1 cover?
- The present disclosure relates to a novel bacteriophage having ability to specifically kill Clostridium perfringens and an antibacterial composition comprising the same. The novel bacteriophage CJ_CP_20-25 has the effect of specifically killing Clostridium perfringens, exhibits excellent acid resistance and heat resistance, and can thus be widely used in antibiotics, feed additives, drinking wa…
- Who is the assignee on this patent?
- Cj Cheiljedang Corp
- What technology area does this patent fall under?
- Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Thu May 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).